SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-11-005486
Filing Date
2011-09-22
Accepted
2011-09-22 16:37:33
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 TARO PHARMACEUTICAL INDUSTRIES LTD. 20-F a6866933.htm 20-F 3563101
2 EXHIBIT 12.1 a6866933ex12_1.htm EX-12.1 14785
3 EXHIBIT 12.2 a6866933ex12_2.htm EX-12.2 13856
4 EXHIBIT 13 a6866933ex13.htm EX-13 8766
5 GRAPHIC header.jpg GRAPHIC 7249
6 GRAPHIC footer.jpg GRAPHIC 14207
7 GRAPHIC eylogo.jpg GRAPHIC 3806
  Complete submission text file 0001157523-11-005486.txt   3636773
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22286 | Film No.: 111103353
SIC: 2834 Pharmaceutical Preparations